Lung volume measurements in infants with and without chronic lung disease.
Infants born prematurely who develop chronic lung disease (CLD) have airways obstruction and hence may have low lung volume. The aim of this study was to test that hypothesis and ascertain whether the nature of the comparison control group influenced the results. Sixteen infants who were oxygen dependent for more than 28 days (CLD) and eight infants without CLD had measurements of functional residual capacity (FRC) at 14 and 28 days. The 16 CLD infants consisted of eight less than 27 weeks gestational age (group A) and eight greater than 26 weeks gestational age (group B). The eight infants without CLD (group C) were each matched for gestational age and gender to infants in group B. Group A compared to group C had lower FRCs both at 14 days (median 18 ml/kg vs 27 ml/kg, P < 0.01) and 28 days (median 20 ml/kg vs 26 ml/kg, P < 0.05), but group A differed from group C with respect to both gestational age (P < 0.01) and birth weight (P < 0.01). The FRC results of group B were lower than those of their matched controls (group C) only at 28 days (median 22 vs 26 ml/kg, P < 0.05). Overall, the FRC results at 14 and 28 days correlated significantly with the duration of oxygen and ventilator dependence and weakly with gestational age.


CONCLUSIONS
These results support the hypothesis that FRC results are lower in infants with CLD compared to those without CLD when measured in the neonatal period and emphasize the importance of an appropriate control group. Measurement of lung volume may facilitate assessment of the response to therapies for CLD.
Kavvadia
V
V
Dept. of Child Health, King's College Hospital, London, UK.
Greenough
A
A
Dimitriou
G
G
Itakura
Y
Y
D001724:Birth Weight; D005260:Female; D005652:Functional Residual Capacity; D005865:Gestational Age; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008173:Lung Diseases, Obstructive / Q000175:diagnosis* / Q000628:therapy; D008176:Lung Volume Measurements; D008297:Male; D010102:Oxygen Inhalation Therapy; D011446:Prospective Studies; D012016:Reference Values; D012127:Respiratory Distress Syndrome, Newborn / Q000175:diagnosis* / Q000628:therapy; D012307:Risk Factors; D012680:Sensitivity and Specificity